carbamazepine has been researched along with loxapine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Keepers, GA | 1 |
| Collins, DM; Gidal, BE; Pitterle, ME | 1 |
| Askenazy, F; Benoit, M; Dor, E; Dupuis, G; Myquel, M; Seddiki, Y; Serret, S | 1 |
| Askenazy, F; Dor, E; Fernandez, A; Menard, ML; Thümmler, S | 1 |
3 review(s) available for carbamazepine and loxapine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Potential interaction between carbamazepine and loxapine: case report and retrospective review.
Topics: Adult; Carbamazepine; Drug Interactions; Drug Monitoring; Female; Humans; Loxapine; Male; Middle Aged; Prospective Studies; Retrospective Studies | 1993 |
6 other study(ies) available for carbamazepine and loxapine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neuroleptic malignant syndrome associated with withdrawal from carbamazepine.
Topics: Adult; Carbamazepine; Humans; Loxapine; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders; Substance Withdrawal Syndrome | 1990 |
[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Cataplexy; Catatonia; Clonazepam; Combined Modality Therapy; Critical Care; Drug Therapy, Combination; Female; Follow-Up Studies; Haloperidol; Humans; Infusions, Intravenous; Loxapine; Neuroleptic Malignant Syndrome; Psychotic Disorders; Social Adjustment; Young Adult | 2010 |
[Carbamazepine and psychotropic treatment interaction: Two case studies of carbamazepine overdosage].
Topics: Adolescent; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Overdose; Drug Therapy, Combination; Female; Fluoxetine; Humans; Loxapine; Mental Disorders; Risperidone | 2015 |